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Concentrations of C3a and C4a anaphylatox ins in suction 
blister fluid s were determined by radioimmunoassay in pa-
tients wi th psoriasis and normal controls. Comparison of 
anaph ylatoxin levels between serum sa mpl es and bliste r 
conten ts in the sa m e subj ects revealed that the levels of 
both C3a and C4a ana ph yla toxins were signi fican tly higher 
in the former th an the lat ter even in those raised on normal 
skip , suggesting that the classic compl ement pathway is 
activa ted durin g suction procedure. Therefore we cannot 
regard suction blister fluid to be simpl y representative of 
I dentification of va rious chemica l mediators is indispensible for the elucidation of the mecl13nisms un derl ying the de-velopment of inflammation . For the anal ysis of earlier in-fl ammatory events we ca n use scale extracts w hi ch reta in responsible chemical med iators [1) . On the other hand, to 
analyze active substa nces that take pa rt in an ongo ing inflam-
matory process, we have had to use freshl y obtained biopsy sam-
ples or skin perfusate fluid collected after intracutaneous injection 
of in nocuous fluid [2]. In contrast to these in vas ive methods, 
rais ing a suction blister on the skin surf.lce by app lying negative 
pressure w hi ch produces dermal-epidermal separation at the level 
of the lamina lucida has become a popular m ethod for collecting 
tissue fluid, as this technique is regarded a far less damaging to 
the tissues than other methods [2,3); the blister fluid has been 
accepted to be idea ll y representative of intersti tial fluid [4,5). 
In chara cteristic psoriatic lesions there occurs cycl ic transepi-
dermal leukocyte mig ration [6). We demonstrated the presence 
of specific chemotactic peptide(s) in psoriatic scale which is thought 
to playa key role in the development of thi s phenomenon , and 
obtained evidence that it conta ins complcment-derived chemo-
tactic facto r [1]. In ad di tion, leukotriene B4 , the most potent lipid 
chem oattractant of 5-lipoxygenase product, was aho identifi ed 
in chamber fluid of psoria tic lesions [7] or in psoriatic scale extracts 
[8,9]. w hi ch co uld function along w ith chcmotactic anaphylatoxin 
to induce ncutrophil migration into psoriatic epidermis. Recently 
we have found incrcased amounts of C5 cleavage fragments (either 
C5a or C5adcs arg) in psoriatic scale extracts together w ith other 
anaph ylatoxins, C3a and C4a [1 0). T hey are also increased in sera 
of psoriatic pati en ts [11] . These findings suggest thc occurrencc 
of classical complement pathway activation in psoriatic patients. 
In the present study, to obtain more direct information abou t 
the complement system in lesional skin , wc have mcasured C3a 
Manuscript received October 3, 1985; accepted for publica tion January 
30, 1986. 
Supported by Grants-in-A id for Scientific Research 5940244 from thc 
Ministry of Education, Science and Culture, Japan. 
Reprint req uests to: Hachiro Tagami, M.D., Department of Derma-
tology, Tohoku University School of Med icin e, 1-1 Sciryo-machi , Sendai 
980, Japan. 
undisturbed interstitial tissue fluid as fa r as the co mplement 
sys tem is concerned. 
There was no difference in anaphylatoxin levels between 
those from uninvolved skin of psoriati c patients and those 
from no rmal controls. However, significantly high ana-
phylatoxin levels were noted in fluid s of suction blisters 
raised on lesional skin as compared with those produced 
on unin volved skin in psoriatic patients. J InlJest Dennatol 
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and C4a anaphylatoxin levels in suction blister contents raiscd in 
psoriatic lesions. However, we have fo un d that complement ac-
tivation takes place probably through the classical pathway during 
the production procedure of suction blister cven in norm al skin . 
MATERIALS AND METHODS 
Subjects Sixteen psoriatic patients (12 m ales and 4 females, 
ranging in age from 19-82 years w ith a mean of 49 years) and 
12 healthy vo lunteers (11 males and 1 female aged 10-34 years 
w ith a mean agc of 29 yea rs) were studied. N one of the patients 
had rcceived any kind of treatment for at least 2 weeks before 
exa mination. 
Suction Blister Formation Blisters were produced on the skin 
of the abdomcn with an attachmcnt device using a hollow syringe-
cylinder aftc r rem oving a piston from a 2-ml disposable sy rin ge 
Gintan Pharmacological Co., Tokyo), w hose broad and flat end 
was placed on the skin and a negative pressure of 200 mm Hg 
was applied fro m a rubber suction tube connected to a nozzle 
portion of the sy ringe. Suction blisters coul d be raised evcn in 
lesiona l sk in w ithin a fcw hours in thc sa me way as on normal 
skin if thc lcsional skin was not covered with thick sca les. Thcre 
was no appreciable differcncc in req uired suction time betwcen 
in volvcd and unin volvcd skin. If the collected amount was not 
sufficient for the measurement of the 2 anaphylatoxin levels, at 
least one anaphylatoxi n level was determined . 
In subj ects in w hom a com parison of the anaphylatoxin levcls 
between serum and suction blister fluid was performed, the blood 
samples were also obtained at the termination of suction. T he 
collected blistcr fluids and fres hl y separa tcd serum samples were 
stored in the presence of EDT A at - 70°C as described previously 
(8). 
Radioimmunoassay Radioimmunoassays for human C3a and 
C3adcs arg' C4a and C4adcs arg' referred to here collectively as C3a 
and C4a, were performed as reported preVIOusly [10-12]. T he 
assay kits for C3ades arg and C4ade, arg were obtained from U pjohn 
D iagnostics (Ka lamazoo, Michigan) and the assays were ca rried 
out according to the manu facturer's instructions . 
Statistical Analysis Means and standard deviations were cal-
cul ated and shown. Levels of ana ph yla toxins were compared us-
ing Student's I-tes t or the W ilcoxon rank-sum test. 
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RESULTS 
Comparison of Anaphylatoxin ,Levels Between Serum and 
Fluid from Suction Blister Raised on Normal Skin The 
effect of suction of normal skin to produce dermal-epidermal 
sepa ration on ana phylatoxin levels was investigated by comparing 
C3a and C4a anaphylatoxin levels between serum and suction 
blister fluid in the same individ uals consisting of 2 control subjects 
and 3 psoriatic patients, The anaphylatoxin levels in suction blister 
fluid s were found to be 3-14 times more than those of the re-
spective serum samples (Fig 1) , Hence, the mean values of both 
C3a and C4a levels in blister fluids were signifi cantly higher than 
those of the serum levels (p < 0,001), 
There was no correlation between the levels of serum samples 
and those of blister contents, suggesting that anaphylatoxins are 
produced in the skin independent of their serum concentrations , 
Anaphylatoxin Levels in Suction Blisters Produced in Pso-
riatic Lesions The mean values of C3a and C4a in the blister 
fluids obtained from uninvol ved paralesional skin of psoriatic 
patients were 981 ± 693 ng/ml (n = 13) and 869 ± 416 ng/ ml 
(n = 16), respectively, neither of which differed significantly from 
the corresponding va lues noted in blisters raised in normal sub-
jects, i,e" 940 ± 259 ng/ml (n = 10) and 739 ± 322 ng/ ml 
(n = 10) (Fig ,2), 
In contras t, significantly high anaphylatoxin concentrations were 
noted in the blister contents obtained from lesional skin, i,e" 
1986 ± 1099 ng/ ml for C3a (n = 14) (p < 0,005 against those 
of normal controls and p < 0,025 against those of uninvolved 
psoriatic skin) and 1365 ± 604 ng/ml for C4a (n = 14) (p < 
0,005 against th ose of normal controls and p < 0,025 against those 
of uninvolved psoriatic skin) , When a comparison was made in 
5 patients in whom all the data of serum and blister fluids taken 
from both uninvolved and involved skin were available, these 
differences became much more apparent (data not shown), 
DISC USSION 
T he present study was designed to extend our previous investi-
gation about eleva ted levels of both C3a and C4a anaphylatoxins 
in psoriatic lesional scales [10] which sugges ted a preceding event 
involving the classical complement pathway activation in the le-
sional skin , We also found definitely higher serum anaphylatoxin 
concentrations in psoriatic patients [11] , If suction blisters simply 
contain leaked serum components by passive diffusion [4], their 
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Figure 1. Comparison of C3a (a) and C4a (b) anaphylatoxin levels be-
tween serum and suction blister content in the same individuals, Open 
circles represent the values of healthy volunteers and closed circles those of 
psoriatic patients, 
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Figure 2. Levels ofC3a (a) and C4a (b) anaphylatoxins in suction blisters 
ra ised in normal subjects and those in blisters produced in uninvolved 
and involved skin of psoriatic patients, Bars represent mean vah~es , 
anaphylatoxin levels should reflect the serum levels, However, 
we found that the levels of anaphylatoxins in blister contents did 
not correla te well with those of the corresponding serum levels 
but that their levels were much higher in suction blister fluids 
than in sera. 
In the present investiga tion we used serum instead of plasm a 
which is conventionally used as a sample for radioimmunoassay 
of complement split products in the blood [12] . The reason was 
that in our former study [11] we used serum instead of plasm a 
to determine the blood anaphylatoxin concentrations; in our pre-
liminary study , we did not find any significant difference in an-
aphylatoxin levels between serum and plasma when they were 
compared in the same subjects. Therefore, the present results 
clearly indicate that the anaphylatoxin levels in suction blister 
fluid s are remarkably higher than those in the blood. 
Clemmensen et al [13] found a minor increase in C3-split in 
suction blister flu id taken from normal skin by crossed immu-
noelectrophoresis. Our present study has provided definite evi-
dence for the complement activation takin g place during the pro-
duction of suction blisters . 
Detection of increases in both C4a and C3a levels suggests the 
classical complement pathway activation. T he procedure to raise 
a suction blister on the skin has been accepted as a rather non-
invasive way for obtaining chemical mediators present in the 
tissue fluid [2] . However, it is now clear that, as far as the com-
plement system is concerned, the bEster fluid is not a simple 
transudate from the peripheral blood. This is a distinct difference 
from the case of other serum proteins or chemical mediators of 
inflammation [2,5,7,14]. We think that forced accumulation of 
tissue fluid in a certain portion of the skin by applying negative 
pressure may increase the chance for serum complement com-
ponents to be exposed to usually hidden tissue components which 
have a property to activate the classical complement pathway. 
Several possible sources are suggested for the high levels o f 
anaphylatoxins in suction blister contents from lesional skin. In 
addition to those ana phyla toxins that have already been produced 
in situ before the production of suction blisters, there is a pos-
sibility that large amounts of fresh ana phyla toxins are produced 
during the formation of suction blisters . Since even normal skin 
components activate complement during the production of suc-
tion blisters, it is quite possible that complement activation occurs 
to a much larger extent during suction blister formation in pso-
riatic lesions which are rich in infiltratin g cells and inflammatory 
exudate with enhanced levels of various proteinases [15] , In in-
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volved psoriatic tissue there are both enhanced levels of serine 
proteinase [16] and polymorphonuclear leukocy tes which have 
the capability to directl y cleave CS to produce chemotactic CSa 
anaphylatoxin and to activate both the alternative and classic path-
ways [17,18]. However it remains obscure exactly what tissue 
components in psoriatic lesions are responsible for the production 
of C3a an d C4a anaphylatoxins in suction blisters. Furthermore, 
it is possible that an tigen-antibody complexes in the skin of pso-
riati c patients [1 9,20] may activa te the complement system. 
In conclusion, the procedure to raise suction blisters on the skin 
induces classic complement path way activation. T herefore, al-
though there ma y be increased amounts of anaphylatoxins in 
pso riatic lesional skin , it is difficult to determine the exact in situ 
concentrations of C3a and C 4a ana phylatoxins from the analysis 
of the suction blister contents. 
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